Lagatar24 Desk
New Delhi, April 9: A single dose of Covishield and Covaxin from the Serum Institute of India and Bharat Biotech respectively would now cost Rs 225 in private hospitals. The dose would be administered at a cost of Rs 150 by the hospitals.
SII CEO Adar Poonawalla said in a tweet on Saturday that after consulting with the central government, the vaccine maker has decided to reduce the price of the Covid-19 vaccine for private hospitals from Rs 600 to Rs 225.
We are pleased to announce that after discussion with the Central Government, SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs.600 to Rs 225 per dose. We once again commend this decision from the Centre to open precautionary dose to all 18+.
— Adar Poonawalla (@adarpoonawalla) April 9, 2022
Similarly, Suchitra Ella, co-founder of Bharat Biotech, revealed that the vaccine company has opted to reduce the price of Covaxin for private hospitals to Rs 225 per dosage, down from Rs 1,200 previously. She went on to say that the decision was made in cooperation with the central government.
Announcing #CovaxinPricing .
We welcome the decision to make available precautionary dose for all adults. In consultation with the Central Government, we have decided to revise the price of #COVAXIN from Rs 1200 to Rs 225 per dose, for #privatehospitals.🇮🇳💉💉💉😷— Suchitra Ella (@SuchitraElla) April 9, 2022
The Union Health Ministry said on Friday that from April 10, preventative doses of Covid-19 vaccine would be accessible at private immunisation centres to all adults over the age of 18.
Those seeking a booster dose must wait nine months after receiving the second treatment, according to officials from the Union Health Ministry.
Since the nationwide immunisation campaign began in January of last year, about 96 percent of people over the age of 15 have gotten at least one dose of the Covid-19 vaccine. At the same time, 83% of people have got both Covid-19 vaccination doses.
Furthermore, over 2.4 crore precautionary dosages have been given to healthcare staff, frontline workers, and people aged 60 and up.
According to government data, 45 percent of 12-14-year-old beneficiaries had gotten their first dose of the Covid-19 vaccine.